New York, NY -- (SBWIRE) -- 01/30/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Generex Biotechnology Corporation(OTCMKTS:GNBT), Berkshire Hathaway Inc.(NYSE:BRK.B), Aratana Therapeutics Inc(NASDAQ:PETX), Gevo, Inc.(NASDAQ:GEVO)
Generex Biotechnology Corporation(OTCMKTS:GNBT) managed to keep its gain at 1.17% on below-normal volume of 4.11Mshares. The stock settled at $0.0459, after floating in a range of $0.04 - 0.05. Its latest price has reached market capitalization of $28.45M. Its 52-week range has been $0.02 - 0.07. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes.
Should Investors Trade GNBT Now? Don’t Miss out a Special Trend Analysis
Berkshire Hathaway Inc.(NYSE:BRK.B) trading on a volume of 3.91M shares, higher than its standard daily volume. Shares have been closed at $111.28. Over the last twelve months, the stock has gained 14.26 % and faced a worst price of $96.30. Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities.
Is BRK.B a Solid Investment at These Levels? Read This Report for Details
Aratana Therapeutics Inc(NASDAQ:PETX) is up at $19.75 on above- normal volume of 3.90M shares during the last trading day. The stock has its 12-month range $ 6.56 - 29.32. Its Intraday range is $ 19.15 - 19.97. Aratana Therapeutics, Inc. is a development-stage biopharmaceutical company. As of March 20, 2013, the Company has three licensed compounds in development for six product approvals in cats and dogs in each of the United States and Europe.
How Should Investors Trade PETX Now ? Don’t Miss out a Special Trend Analysis
In the last trading day, Gevo, Inc.(NASDAQ:GEVO) is on high volume, trading at a volume of versus its average daily volume ratio 3.90M/1.25M shares. At $1.36 the stock has attained market capitalization of 64.17M. Gevo, Inc., is a renewable chemicals and advanced biofuels company.
Will Investors Buy GEVO After Reading This News? Just Go Here And Find Out
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)